Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00240
|
|||||
| Drug Name |
Trandolapril
|
|||||
| Synonyms |
(2S,3aR,7aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)hexahydro-2-indolinecarboxylic acid, 1-ethyl ester; (2S,3aR,7aS)-1-(N-((1S)-1-((Ethyloxy)carbonyl)-3-phenylpropyl)-L-alanyl)octahydro-1H-indole-2-carboxylic Acid; (2S,3aR,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylicacid; 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-1H-indol-2-carboxylic acid; Gopten; Mavik; Mavik (TN); Odric; Odrik; Preran; RU 44570; RU-44570; RU44570; Trandolapril (JAN/INN); Trandolapril [INN:BAN]; Trandolaprilum; Trandolaprilum [Latin]; Udrik
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | High blood pressure [ICD11: BA00] | Approved | [1] | |||
| Therapeutic Class |
Antihypertensive Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C24H34N2O5
|
|||||
| Canonical SMILES |
CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCCC3CC2C(=O)O
|
|||||
| InChI |
InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1
|
|||||
| InChIKey |
VXFJYXUZANRPDJ-WTNASJBWSA-N
|
|||||
| CAS Number |
CAS 87679-37-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 430.5 | Topological Polar Surface Area | 95.9 | ||
| Heavy Atom Count | 31 | Rotatable Bond Count | 10 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103558689
, 113992926
, 118048541
, 12013675
, 121361634
, 124893803
, 126662049
, 131328953
, 134223023
, 134337874
, 135060465
, 135569875
, 135723472
, 136043950
, 137002500
, 139097173
, 144205006
, 144206703
, 14807551
, 14929957
, 151982735
, 152035469
, 160848877
, 160963864
, 162176909
, 163122933
, 163564878
, 164813794
, 17185447
, 172919751
, 175266111
, 175612605
, 178103069
, 179116928
, 184545941
, 210279756
, 210282079
, 223702475
, 224010570
, 39472377
, 46508300
, 48416651
, 49983793
, 57364037
, 7847449
, 78587898
, 7980822
, 90340949
, 93166962
, 93619661
|
|||||
| ChEBI ID |
CHEBI:9649
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [2] | |
| PEPT2 | Transporter Info | Peptide transporter 2 | Substrate | [2] | ||
| References | ||||||
| 1 | Trandolapril was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited. J Pharmacol Exp Ther. 2008 Nov;327(2):432-41. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.